baber/WOPTO huggingface dataset:
Patent IE-850985-L (IE)
Title: Salts of fosfomycin with imidazole
IPC: A61K31/44
Filed: 1985-04-16
Abstract: This invention provides new medicaments having coronary vasodilatory activity of superior degree and durability, these being diastereoisomer A of 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-(benzylpyrrolidin-3-yl) ester 5-methyl ester, the melting point of the hydrochloride of this diastereoisomer A being 200 to 206 DEG C (decomp); the dextro-rotatory isomer of this diastereoisomer A; and pharmaceutically acceptable acid addition salts of these compounds. The medicament compounds of the invention can be separated from admixture with other isomers by various methods including chromatography and fractional crystallisation.
Patent IE-811158-L (IE)
Title: Laminating process
IPC: G03F7/16
Filed: 1981-05-25
Abstract: In a process for laminating a photosensitive layer to a substrate surface by means of pressure, the improvement comprising the sequential steps of: (a) applying a thin layer of liquid on the substrate surface immediately prior to lamination, which layer forms an interface between the substrate surface and the photosensitive layer upon lamination, the liquid being a nonsolvent with respect to the photosensitive layer; and (b) displacing the thin layer of liquid from the substrate surface by absorption into the photosensitive layer during lamination.
Patent IE-901180-L (IE)
Title: Polar cephalosporin derivatives and a process for the¹preparation thereof
IPC: A61K31/546
Filed: 1990-03-30
Abstract: Polar cephalosporin derivatives of the general formula I <IMAGE> and their physiologically tolerable acid addition salts, pharmaceutical preparations active against bacterial infections and which contain such cephalosporin derivatives, a process for the preparation of the cephalosporin derivatives and of the pharmaceutical preparations and use of the cephalosporin derivatives for the control of bacterial infections.
Patent IE-881241-L (IE)
Title: Floor cleaning utensil
IPC: A47L13/12
Filed: 1988-04-26
Abstract: A cleaning implement for cleaning and mopping surfaces e.g. floors, windows comprises a pad 5 attached to a holder comprising two relatively movable parts 1A, 1C each of which is provided with a handle 3a, 3b, the arrangement being such that the handles may be gripped by a user and pressure applied to move the two holder parts towards each other thereby squeezing the pad. The pad may be a cloth, sponge, a scouring pad, chamois leather, or a bristled or textured material. The holder may be made of metal, wood, or plastics. The pad may be permanently or releasably attached to the holder. The implement may be provided with an auxiliary formation or attachment e.g. brush, scraper, or socket e.g. for a broom handle. <IMAGE>
[GB2203932A]
Patent IE-821353-L (IE)
Title: Radio communications apparatus
IPC: H04K1/00
Filed: 1982-06-04
Abstract: Channel selection in a frequency hopping radio set is controlled by a pseudo-random number generator, the pseudo-random number being used to address an N bit memory (3) which is used to identify each of n available channels from N equipped channels. When a preselected number of the n channels have been identified by the psuedo-random number generator a latch (4) is enabled to store the channel number for selection purposes. Various scrambling methods are employed so that the channels on which one network of radio sets is operating is not readily identifiable from the channels on which another network of radio sets is operating.
[US4476566A]
Patent IE-871462-L (IE)
Title: Benzopyran derivatives
IPC: C07D311/36
Filed: 1987-06-03
Abstract: A benzopyran derivative represented by formula <CHEM>  wherein: R1 and R2 each represents a hydrogen atom, a lower alkyl group, a substituted or unsubstituted cyclic alkyl group, a mono- or di-lower alkylamino group, a substituted or unsubstituted cyclic amino group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted aralkyl group; Y1 and Y2 each represents a hydrogen atom, a lower alkyl group, a halogen atom or a trihalomethyl group; Z represents a carboxyl group, a lower alkoxycarbonyl group, a tetrazolyl group, a hydroxyl group or -CONR3R4 wherein R3 and R4 each represents a hydrogen atom or a lower alkyl group;  n represents an integer of from 1 to 6; and the bond @ between the 2- and 3-positions represents a single bond or a double bond; provided that a combination wherein Y1, Y2, and R2 each represents a hydrogen atom, R1 represents a phenyl group, n represents 1, Z represents a carboxyl group or an alkoxycarbonyl group, and the bond @ represents a double bond, and a combination wherein Y1, Y2, and R1 each represents a hydrogen atom, R2 represents a phenyl group, n represents 1, Z represents a carboxyl group or an alkoxycarbonyl group, and the bond @ represents a double bond are excluded, and pharmaceutically acceptable salts thereof are disclosed. These compounds have uricosuric activity, diuretic activity and antihypertensive activity, and are useful as pharmaceuticals.
Patent IE-781470-L (IE)
Title: Business forms
IPC: B41L1/36
Filed: 1978-07-21
Abstract: {PG,1 A unit set of multiple plies includes superimposed top, intermediate and bottom plies each being devoid of any tear lines which may form a stub, and each being coated on selected surfaces thereof with chemicals which are capable of reacting with one another to produce a colored mark. The top and bottom plies are interconnected by means of a removable glue flap, and portions of the glue extend through holes lying along a margin of the bottom ply so as to thereby interconnect the intermediate and bottom plies together. The top ply is coated front and back and the intermediate ply is coated on its back surface with a micro-encapsulated color precursor, while the bottom ply is coated front and back and the top surface of the intermediate ply is coated with a record-developing material. Upon application of pressure to the set, colored marks are formed on the intermediate and bottom ply top surfaces as the reactive components of the coatings on mating surfaces react. The plies are capable of rearrangement such that by removal of the intermediate ply and by placing the backs of the top and bottom plies in mating engagement {pg,2 colored marks are produced on the backs of the plies as the reactive components of the coatings of these mating surfaces are forced into reactive contact upon the application of pressure to the back of the set.
[US4126334A]
Patent IE-36875-L (IE)
Title: Handling thin walled containers
IPC: B65B43/60
Filed: 1972-11-06
Abstract: Apparatus for handling thin walled containers including a handling unit comprising a plurality of individual container holders each adapted to hold a container in upright manner therein, means maintaining the holders in spaced relationship and defining an endless path, means for moving the holders in said endless path, each of said holders being split vertically to define two parts which are relatively displaceable vertically from a holder closed position to a holder open position in which a container can be moved horizontally into the upper holder part, and means for relatively displacing vertically the holder parts of each holder from the holder closed position to the holder open position and for returning the parts to the holder closed position.
[US3895660A]
Patent IE-851633-L (IE)
Title: Pyrido-indole compounds
IPC: C07D471/04
Filed: 1985-06-28
Abstract: A pharmaceutical composition comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof:wherein:R<sub>1</sub> is hydrogen, C<sub>1-6</sub> alkyl, C<sub>1-6</sub> alkoxy or halogen;R<sub>2</sub> and R<sub>3</sub> are both hydrogen or together represent a bond;R<sub>4</sub> is hydrogen and R<sub>5</sub> is hydrogen or R<sub>4</sub> and R<sub>5</sub> together represent on oxo group;R<sub>6</sub> is hydrogen; C<sub>1-6</sub> alkyl; C<sub>3-7</sub> cycloalkyl; C<sub>3-7</sub> cycloalkyl-C<sub>1-4</sub> alkyl; phenyl or phenyl C<sub>1-7</sub> alkyl in which the phenyl moiety is optionally substituted by one or two of halogen, ortho-nitro, meta-or para-methoxy, methyl or NR<sub>8</sub>R<sub>9</sub> wherein R<sub>8</sub> and R<sub>9</sub> are independently hydrogen or C<sub>1-6</sub> alkyl or R<sub>8</sub> and R<sub>9</sub> together are C<sub>2-6</sub> polymethylene, or 3,4-disubstituted by methylenedioxy or ethylenedioxy; or monocyclic heteroaryl-C<sub>1-4</sub> alkyl or aliphatic heterocyclyl-C<sub>1-4</sub> alkyl of up to six ring atoms, the heteroatom(s) being selected from oxygen, suphur or nitrogen, any amino nitrogen heteroatom optionally C<sub>1-4</sub> alkyl substituted; andR<sub>7</sub> is hydrogen or C<sub>1-4</sub> alkyl; and a pharmaceutically acceptable carrier.
Patent IE-39534-L (IE)
Title: Yarn tension device
IPC: B65H59/22
Filed: 1973-10-05
Abstract: 1446048 Yarn tensioning devices O ZOLLINGER 4 Oct 1973 [16 Oct. 1972 11 June 1973 23 July 1973] 46506/73 Headings DID and D1F A yarn tensioner comprises a housing with a yarn passage therethrough which includes a restricted opening surrounded by a seat e.g. 134 which has a smooth convex arcuate surface on which a spherical element rests, the spherical element being of such a size that when no yarn passes through the device it rests on the seat out of contact with the passage walls and the passage diameter at least adjacent the seat being such that lateral movement of the spherical element is substantially prevented. Threading up can be preformed by an air jet, Fig. 3, which elevates the ball and entrains the yarn end. Alternatively and elongate threading up tool may be employed. More than one spherical element may be employed and an additional large one may be situated at the open end of the device with a retaining member 474 Fig. 6. An alternative smaller retaining member may be employed when the large 'spherical element is not used, Figs. 7 and 8 (not shown). The seat can be formed as an insert and a wear resistant ring can be fitted at the mouth of the device, these parts being suitably made of ceramic material e.g. aluminium oxide. Alternatively the entire housing may be made of this material. The housing may also be made of transparent plastics material. The spherical element is suitably made of stainless steel. The interior of the housing may be slightly flared.
[GB1446048A]
Patent IE-40170-L (IE)
Title: Aliphatic diol polycarbonates
IPC: C08G63/00
Filed: 1974-09-09
Abstract: Hydroxy-telechelating oligomers of number average molecular weight 250 to 2,500 and containing carbonate groups, are prepared by first polycondensing a bis-chloroformate with a diol at a temperature below 150 DEG C and at a moderately reduced pressure while flushing the reaction mixture with an inert anhydrous gas, and then the oligomers formed are dissolved in a volatile, water-immiscible organic solvent and the solution washed with an aqueous base solution.
[US3966788A]
Patent IE-39844-L (IE)
Title: Inflatable life belt
IPC: B23C/
Filed: 1974-09-12
Abstract: An inflatable bouyancy aid comprises an elongate, straight inflatable member, and a securing device attached to and extending from the inflatable member and adapted to encircle the trunk part of the body of a wearer. An actuating device is associated with a gas producing device located in or adjacent the inflatable member such that on operation of the actuating device an amount of gas flows into the inflatable member so as to inflate it and provide buoyancy for the wearer. The securing device extends from two positions spaced apart and removed from each end of the inflatable member to leave two end portions of the inflatable member, when inflated, extending in substantial tangential fashion from the body of the wearer.
[US3952355A]
Patent IE-871981-L (IE)
Title: Programmed release formulation.
IPC: A61K9/54
Filed: 1987-07-22
Abstract: New galenic formulations with programmed release, to be administered by oral route, containing as the active ingredient a compound endowed with antiphlogistic, analgesic and antipyretic activity like, for instance, an arylacetic or an arylpropionic acid and the pharmaceutically acceptable salts thereof. In these new formulations, a portion of the active ingredient is released in a short time, so that the drug can quickly develop its therapeutic action reaching the necessary hematic levels, while the remaining portion of the active constituent is released in a longer interval of time so as to allow the therapeutic coverage till the subsequent administration. Said therapeutic coverage can even last 24 hours; thus the new galenic formulations object of the present invention are suitable for a once a day administration.
[EP0255002A1]
Patent IE-812325-L (IE)
Title: Diester composition and textile processing compositions¹therefrom
IPC: D06M13/152
Filed: 1981-10-05
Abstract: A cycloaliphatic diester of the formula <IMAGE> wherein R is substituted or unsubstituted straight or branched chain C4-C20 alkyl, polyoxyalkylene of the formula HO(CH2CH2O)nCH2CH2-, HO(C3H6O)nC3H6-, HO(CH2CH2O)p(C3H6O)qC3H6-,or HO(C3H6O)p(C2H4O)qC2H4- or phosphated polyoxyalkylene, wherein n is 2-22 and the sum of p+q is n, in combination with a high boiling aromatic ester of formula ArCOO- R1-OOCAr or ArCOOR2 where A is a monocyclic C6-10 aryl R1 is C2-8 alkylene or polyoxyalkylene of formula -CrH2r(O-CrH2r)s where r is 2 or 3 and r is 1-15, and R2 is C8-30 alkyl or alkenyl, is useful in fiber treating and textile processing compositions. Corresponding cycloaliphatic diesters wherein R is Ar'COO(CH2CH2O)nCH2CH2-, Ar'COO(C3H6O)nC3H6-, Ar'COO(C2H4O)pC3H6O)qC3H6-, or Ar'COO(C3H6O)p(C2H4O)qC2H4- and Ar' is substituted or unsubstituted monocyclic aryl can be used as the sole additive.
[GB2089369A]
Patent IE-782436-L (IE)
Title: Butter-like edible fat
IPC: A23D7/015
Filed: 1978-12-08
Abstract: A process for the continuous production of a butter-like edible fat product, spreadable at refrigerator temperature and consisting of cow's cream and 15-30% (based on the total fat content) of a vegetable, tocopherol-containing triglyceride oil, comprising the following steps. First, the fat content of the cream is adjusted to 36-38% by weight, whereupon the cream is cooled to 3 DEG -4 DEG C. and stored for at least 3 hours. Then the cream is pumped in a stream to a continuous butter making machine of the Fritz type. All or a considerable portion of the oil is injected into the stream of cream between the storage and the butter making machine. After admixing, but ahead of the butter making machine, the injected oil is finely divided and emulsified. The relative amounts of the cream and the injected oil in the stream entering the butter making machine is so adjusted to obtain a total fat content of more than 40% by weight. The temperatures are controlled so that the mixture entering the butter making machine will be at 5 DEG -6 DEG C. Churning is effected at a temperature of 5 DEG -7 DEG C. Unless all oil has been injected into the stream, the remaining portion of the product's oil is added to the working section of the butter making machine.
[SE7800900L]
Patent IE-802642-L (IE)
Title: Tetra and penta peptides
IPC: A61P25/04
Filed: 1980-12-16
Abstract: Compounds of the formula <IMAGE> and pharmaceutically acceptable non-toxic acid addition salts thereof, in which L and D define the chirality; R1 is hydrogen or C1-C3 primary alkyl; R2 is C1-C4 primary or secondary alkyl, allyl, cyclopropylmethyl, C1-C2 hydroxyalkyl, or -(CH2)m-U-CH3 in which U is -S- or >S-O and m is 1 or 2; R3 is hydrogen, C1-C4 primary or secondary alkyl, cyclopropylmethyl, or allyl; R4 is hydrogen, C1-C5 primary or secondary alkyl, -(CH2)n-X-(CH2)p-CH3 in which X is -O-, -S-, >S-O or <IMAGE> n is 1 or 2, and p is 0 or 1, phenyl, or monosubstituted phenyl in which the substituent is halo, hydroxy, C1-C3 alkoxy, nitro, C1-C3 alkyl, or trifluoromethyl; R5 is hydrogen or C1-C4 primary alkyl; and Z is -CH2OR6, <IMAGE> in which R6 is hydrogen or C1-C3 alkyl and R7 is C1-C3 alkyl; subject to the proviso that one but not both of R3 and R5 is other than hydrogen; are useful analgesic agents.
[US4283329A]
Patent IE-873397-L (IE)
Title: Morpholinoethylester of mycophenolic acid
IPC: C07D307/88
Filed: 1987-12-15
Abstract: The compounds and pharmaceutical compositions of Formula A, wherein Z is hydrogen or -C(O)R, where R is lower alkyl or aryl, and the pharmaceutically acceptable salts thereof, are useful as immunosuppressive agents, anti-inflammatory agents, anti-tumor agents, anti-viral agents, and anti-psoriatic agents. <CHEM>
Patent NO-820638-L (NO)
Inventor: LUND ANDERS E
IPC: E04H12/04
Filed: 1982-03-01
Abstract: An elongate structural member has a longitudinal axis and is comprised of a plurality of elongate panels having lateral edges, the panels being arranged to form an elongate central cavity with lateral edges of adjacent panels being fixediy joined together. The elongate panels are each comprised of a plurality of wood particles intermixed with a suitable binder and compressed to form a densified product. A rigid foam material is provided filling at least a portion of the elongate central cavity for reinforcing the elongate structure, the rigid foam material also being bonded to the inwardly facing surfaces to further reinforce the elongate structure.
Patent NO-830771-L (NO)
Title: Obduksjonsbord.
Inventor: HOWORTH FREDERICK HUGH
IPC: A61G13/00
Filed: 1983-03-07
Abstract: En bordplate (11) er, i det minste langs én side, forsynt med et antall hylser (15) , som inntaksstusser (16) er utformet til å passe inn i. Når et lik (41) er i ferd med å bli undersøkt, kan en sentrifuge (30) kobles inn for å suge luft tvers over bordplaten (11), inn i stussene (16) og gjennom filtre 28,29 for utblåsning via en kanal. Dette luftstrømningsmønster har vist seg å minimalisere sannsynligheten for at en kirurg skal puste inn skadelige stoffer eller gasser, som stammer fra liket, og stussene (16) hindrer ikke kirurgens adgang til liket.Stussene (16) kan være glidbart innstillbare i hylsene (15) eller forefinnes i en rekke innbyrdes avvikende lengder og/ eller krumninger og være gjensidig utskiftbare, slik at de kan anbringes på optimale nivåer over bordplaten (11) . Blindelementer eller lokk (19) kan blokkere hylser (15) hvor det ikke er behov for noen stusser (16).
Patent NO-840698-L (NO)
Inventor: BOURZAT JEAN-DOMINIQUE
IPC: A61K31/385
Filed: 1984-02-23
Abstract: New derivatives of the general formula (I) in which: R=H or Cl and either R1 and R2 form a tetrahydroquinoxaline, tetrahydroquinoline, tetrahydroisoquinoline, dihydrobenzoxazine, tetrahydro-1H-benzazepine or isoindoline ring, it being possible for all these rings to be substituted by one or more halogen, carboxyl, alkoxycarbonyl, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, trifluoromethyl, cyano, nitro, alkoxy, alkylthio or alkyl, substituted by carboxyl, alkoxycarbonyl, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, hydroxyl, amino, alkylamino or dialkylamino, or R1=alkyl and R2=alkyl substituted by phenyl which is itself unsubstituted or substituted by one or more halogen, alkyl, alkoxy, alkylthio, hydroxy, amino, alkylamino, dialkylamino, carboxy, alkoxycarbonyl, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, trifluoromethyl, cyano or nitro, all the alkyls having 1 to 4 C in a straight or branched chain. These new products are used as antirheumatics.    <IMAGE>  (I)
Patent NO-852587-L (NO)
Inventor: REINHARDTSEN TORE
IPC: F01N1/24
Filed: 1985-06-27
Abstract: Silencer comprising a closed container comprising a side wall (3) having an elliptical shape, a top, a bottom and an input (1) and an output (2). Exhaust gases from a combustion engine are brought into the interior of the container at a first focusing point (4), and being collected in a second focusing point (5) after reflection from the side wall (3). In the second focusing point (5) a sound absorbing material (6) absorbs the sound waves and the gases thereafter exits the silencers through the output (2).
Patent NO-854091-L (NO)
Title: Pumpesystem for fluid.
Inventor: GERLACH CHARLES RICHARD
IPC: B01D53/26
Filed: 1985-10-15
Abstract: Et fluidpumpesystem for bruk med et dehydreringssystem for naturgass eller lignende. som har et absorbsjonsapparat (26) for å fjerne vann fra den våte naturgass for å fremstille tørr naturgass ved bruk av et trkemiddel slik som glykol, og et glykolbehandllngsapparat (34) for å fremstille et forråd av tørr glykol fra våt glykol mottatt fra absorbsjonsapparatet.Systemet innbefatter et hovedlegeme (101) med en sentral boring (158) derigjennom for å motta. en avlang stempelaksel (102), en avlang hovedstempelaksel (102) reslproserbart og glidbart montert i den sentrale boring, første og andre sylindre (103R,103L) avtagbart montert på mot-. satte sider av hovedlegemetringformet, sentrert forhold i forhold til stempelakslen, første og andre hovedstempler (105R,105L) montert ved motsatte ender av stempelakslen og på tettende og glidende måte opptatt i den første og andre sylinder, hvor hvert stempel avdeler et til-. knyttet sylinderhulrom i et pumpekammer (159R,159L) for tørr glykol og et drivkammer (1S2R,162L). for våt glykol, og hvert pumpekammer for tørr glykol er operativt forbundet med et pumpekamraer-innløp (160,160) i fluidkommunikasjon med behandlingsapparatet (34) og et pumpekammerutløp (161R, 161L) i fluidkommunikasjon med absorbsjonsapparatet (26), idet hvert drivkammer (162R,162L) for våt glykol er operativt forbundet med et første og andre reversibelt åpningssystem, hvor hvert reversible åpningssystem har en innstrømmende driftsstilling hvor et tilknyttet drivkammer / anbringes i fluidkommunikasjon med våtglykolen i absorbsjonsapparatet og som har en utstrømmende /. driftsstilling hvor et tilknyttet drivkammer anbringes i fluidkommunikasjon med behandlingsapparatet. Avtagbare stempeltappelement (154,155) av forskjellige dimensjoner foreligger for. å variere en volumetrisk ubalanse mellom pumpekammeret og drivkammeret.
Patent NO-861977-L (NO)
Inventor: BREWER DONALDEE
IPC: G05D16/06
Filed: 1986-05-16
Abstract: This invention is directed to a differential control valve. The differential pressure is maintained by differing area surfaces on a piston assembly which will be balanced at a predetermined differential established at the manufacturing operation. There is a spring member operating on two valve balls which provides a delayed pressurization of the controlled chamber. The control valve has a ball valve at the exit port to control the low pressure side of the differential control valve assembly, providing a fail-safe system with no adjustments required after manufacture if there is a pressure increase downstream.